Global Cancer Therapy Market Size, Trends, and Growth Opportunity, By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, and Other Therapy Types), By Cancer Type (Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Respiratory/Lung Cancer, and Other Cancer Types), By End User (Hospitals, Specialty Clinics, and Cancer and Radiation Therapy Centers), By Region and Forecast to 2030.
Global Cancer Therapy Market
The Global Cancer Therapy Market was valued at USD 180.5 billion in 2022 and is expected to expand to USD 360.1 billion by 2030, at a CAGR of 7.80% during the forecast period 2023-2030.
Cancer therapy is the process of radiation, surgery, medications, and other related therapies to shrink cancer, cure cancer, or stop the progression of cancer. Many cancer treatments exist. Various types of targeted therapies help in cancer treatment by interfering with a protein that helps tumors grow and spread throughout the body. This therapy is different from chemotherapy, which often kills all cells that grow and divide quickly.
Market Drivers
The increasing assistance programs, the increase in government initiatives for cancer treatment & awareness, the rising prevalence of cancer globally, and strong R&D initiatives from key vendors, along with the rising demand for personalized medicine are factors that are driving the global cancer therapy market.
Furthermore, major organizations in the market are focused on receiving government and other regulatory body approvals for their products, which is expected to drive the overall market growth over the forecast period of 2030.
Market Restraints
However, potential side effects related to different cancer therapies and treatments such as the cost of cancer therapies, especially in low- and middle-income countries, and loss of bone mass can be challenging factors for cancer therapy market growth.
Market Segmentation
The global cancer therapy market is segmented into therapy type, cancer type, end user, and region.
Based on therapy type, the global cancer therapy market is segmented into chemotherapy, targeted therapy, immunotherapy, hormonal therapy, and other therapy types.
Based on end users, the market is segmented into hospitals, specialty clinics, and cancer and radiation therapy centers.
Regional Analysis
The global cancer therapy market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North American region is expected to dominate the global cancer therapy market share in the future, due to the increased adoption of cancer therapy and the growing burden of cancers in the USA. According to the Globocan 2020 report, an estimated 2,280,658 new cancer cases were diagnosed in the U.S. in the year 2020, with nearly 612,391 deaths. In 2020, the most common cancers were breast (253,466), lung (227,876), prostate (209,514), and colon (101,807) in the USA.
Key Players
Various key players are discussed in the global cancer therapy market report including; Pfizer Inc., Novartis AG, Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline PLC, Hoffmann-La Roche Ltd., Bayer AG, AstraZeneca, Amgen, Bristol-Myers Squibb Company, and others
For instance, in May 2022, F. Hoffmann-La Roche Ltd., launched PHESGO, a combination of Perjeta and Herceptin with hyaluronidase, administered by subcutaneous injection with intravenous (IV) chemotherapy, for the treatment of early and metastatic breast cancer.
Market Taxonomy
By Therapy Type
• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Hormonal Therapy
• Other Therapy Types
By Cancer Type
• Blood Cancer
• Breast Cancer
• Prostate Cancer
• Gastrointestinal Cancer
• Gynecologic Cancer
• Respiratory/Lung Cancer
• Other Cancer Types
By End User
• Hospitals
• Specialty Clinics
• Cancer and Radiation Therapy Centers
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Global Cancer Therapy Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Cancer Therapy Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact Due To Recent Energy Crisis
4.2.5 Cumulative Impact Due Nearing Economic Downturn
4.2.6 Post Covid-19 World Supply and Demand Conditions
4.2.7 Cumulative Impact Of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Cancer Therapy Market, By Therapy Type
5.1 Y-o-Y Growth Comparison, By Therapy Type
5.2 Global Cancer Therapy Market Share Analysis, By Therapy Type
5.3 Global Cancer Therapy Market Size and Forecast, By Therapy Type
5.3.1 Chemotherapy
5.3.2 Targeted Therapy
5.3.3 Hormonal Therapy
5.3.4 Immunotherapy
5.3.5 Other Therapy Types
6 Global Cancer Therapy Market, By Cancer Type
6.1 Y-o-Y Growth Comparison, By Cancer Type
6.2 Global Cancer Therapy Market Share Analysis, By Cancer Type
6.3 Global Cancer Therapy Market Size and Forecast, By Cancer Type
6.3.1 Blood Cancer
6.3.2 Breast Cancer
6.3.3 Prostate Cancer
6.3.4 Gastrointestinal Cancer
6.3.5 Gynecologic Cancer
6.3.6 Respiratory/Lung Cancer
6.3.7 Other Cancer Types
7 Global Cancer Therapy Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Cancer Therapy Market Share Analysis, By End User
7.3 Global Cancer Therapy Market Size and Forecast, By End User
7.3.1 Hospitals
7.3.2 Specialty Clinics
7.3.3 Cancer and Radiation Therapy Centers
8 Global Cancer Therapy Market, By Region
8.1 Global Cancer Therapy Market Share Analysis, By Region
8.2 Global Cancer Therapy Market Share Analysis, By Region
8.3 Global Cancer Therapy Market Size and Forecast, By Region
9 North America Cancer Therapy Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Cancer Therapy Market Share Analysis, By Therapy Type
9.3 North America Cancer Therapy Market Share Analysis, By Cancer Type
9.4 North America Cancer Therapy Market Size and Forecast, By End User
9.5 North America Cancer Therapy Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Cancer Therapy Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Cancer Therapy Market Share Analysis, By Therapy Type
10.3 Europe Cancer Therapy Market Share Analysis, By Cancer Type
10.4 Europe Cancer Therapy Market Size and Forecast, By End User
10.5 Europe Cancer Therapy Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe
11 Asia Pacific Cancer Therapy Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Cancer Therapy Market Share Analysis, By Therapy Type
11.3 Asia Pacific Cancer Therapy Market Share Analysis, By Cancer Type
11.4 Asia Pacific Cancer Therapy Market Size and Forecast, By End User
11.5 Asia Pacific Cancer Therapy Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Rest of Asia Pacific
12 Latin America Cancer Therapy Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Cancer Therapy Market Share Analysis, By Therapy Type
12.3 Latin America Cancer Therapy Market Share Analysis, By Cancer Type
12.4 Latin America Cancer Therapy Market Size and Forecast, By End User
12.5 Latin America Cancer Therapy Market Size and Forecast, Country
12.5.1 Brazil
12.5.2 Rest of Latin America
13 Middle East Cancer Therapy Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Cancer Therapy Market Share Analysis, By Therapy Type
13.3 Middle East Cancer Therapy Market Share Analysis, By Cancer Type
13.4 Middle East Cancer Therapy Market Size and Forecast, By End User
13.5 Middle East Cancer Therapy Market Size and Forecast, By Country
13.5.1 Saudi Arabia
13.5.2 UAE
13.5.3 Egypt
13.5.4 Kuwait
13.5.5 South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market Share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Pfizer Inc.
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Novartis AG
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.25 Key Market Developments
15.2.6 Key Strategies
15.3 Merck & Co. Inc.
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Johnson & Johnson
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 GlaxoSmithKline PLC
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Hoffmann-La Roche Ltd.
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Bayer AG
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 AstraZeneca
15. 8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Amgen
15.9.1 Overview
15.9.2 Offerings
15.4.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Bristol-Myers Squibb Company
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
